Djibouti Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Djibouti Health Journal.

Press releases published on April 21, 2026

Apr. 21, 2026

Cogent Biosciences Announces Oral Presentation of Positive Phase 3 PEAK Trial in Gastrointestinal Stromal Tumors (GIST) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

Indeterminate GlobeNewswire

Apr. 21, 2026

Humacyte Announces Israeli Ministry of Health Acceptance of Marketing Authorization Application for Symvess® for Vascular Trauma Repair

Indeterminate GlobeNewswire

Apr. 21, 2026

Vystar and R3alm Launch R3alm.com Following Strategic Transaction

Indeterminate GlobeNewswire

Apr. 21, 2026

BioRestorative Therapies Announces Strategic Partnership with Global Dermatology Leader Dr. David J. Goldberg to Lead Clinical Evaluation and Seek Multi-Channel Adoption of Its Regenerative BioCosmeceutical Platform

Indeterminate GlobeNewswire

Apr. 21, 2026

PatchMD Appoints Bradley Keys as Chief Marketing Officer

Indeterminate GlobeNewswire

Apr. 21, 2026

Sotera Health Announces First-Quarter 2026 Earnings Release Date

Indeterminate GlobeNewswire

Apr. 21, 2026

Plus Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement 

Indeterminate GlobeNewswire

Apr. 21, 2026

Corvus Pharmaceuticals to Host Investor and Analyst Meeting on May 14, 2026 to Highlight Soquelitinib Data Being Presented at the Society for Investigative Dermatology (SID) Annual Meeting

Indeterminate GlobeNewswire

Apr. 21, 2026

BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ in Preclinical Cancer Models

Indeterminate GlobeNewswire

Apr. 21, 2026

Annual General and Special Meeting of Shareholders to be held May 7, 2026

Indeterminate GlobeNewswire

Apr. 21, 2026

Medicenna Presents Positive Data Demonstrating Superior Safety and Efficacy Potential of its First-in-Class anti-PD-1 x IL-2 Bifunctional Superkine MDNA113 at AACR 2026

Indeterminate GlobeNewswire

Apr. 21, 2026

BPGbio Appoints Former Oxford Pro-Vice Chancellor for Innovation Chas Bountra, Ph.D., as Executive Vice President and Chief Scientific Officer

Indeterminate GlobeNewswire

Apr. 21, 2026

Standard BioTools to Announce First Quarter 2026 Financial Results on May 5, 2026

Indeterminate GlobeNewswire

Apr. 21, 2026

BioAge Reports Positive Phase 1 Data for BGE-102, a Novel Oral NLRP3 Inhibitor, Demonstrating Potential Best-in-Class Reductions in hsCRP

Indeterminate GlobeNewswire

Apr. 21, 2026

Eupraxia Pharmaceuticals Reports Positive Nine-Month Tissue Health and Symptom Data from the Highest Dose Cohort in its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis 

Indeterminate GlobeNewswire

Apr. 21, 2026

Rezolute to Present Results from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism at the Pediatric Endocrine Society (PES) Annual Meeting

Indeterminate GlobeNewswire

Apr. 21, 2026

Kala Bio Celebrates Trump Executive Order as Game-Changer for Psychedelic Medicine

Indeterminate GlobeNewswire

Apr. 21, 2026

XORTX Meets Nasdaq Continued Listing Requirements

Indeterminate GlobeNewswire

Apr. 21, 2026

Independent Nonclinical Research on Lasofoxifene Presented at American Association for Cancer Research Annual Meeting 2026 Consistent with LeonaBio’s Data

Indeterminate GlobeNewswire

Apr. 21, 2026

AAVantgarde announces completion of recruitment in STELLA natural history study

Indeterminate GlobeNewswire